QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.070516v1 311/2/568    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Loutrari, H. Articles by Papapetropoulos, A. Search for Related Content PubMed PubMed Citation Articles by Loutrari, H. Articles by Papapetropoulos, A.

CARDIOVASCULAR

Perillyl Alcohol Is an Angiogenesis Inhibitor

G.P. Livanos and M. Simou Laboratories, Evangelismos Hospital, Department of Critical Care and Pulmonary Services, Medical School, University of Athens, Athens, Greece (H.L., C.R.); Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Greece (M.H., E.P., A.P.); and Biotechnology Laboratory, School of Chemical Engineering, National Technical University of Athens, Athens, Greece (V.S., F.K.)

Aberrant angiogenesis is essential for the progression of solid tumors and hematological malignancies. Thus, antiangiogenic therapy is one of the most promising approaches to control cancer. In the present work, we examined the ability of perillyl alcohol (POH), a dietary monoterpene with well-established tumor chemopreventive and chemotherapeutic activity, to interfere with the process of angiogenesis. POH remarkably prevented new blood vessel growth in the in vivo chicken embryo chorioallantoic membrane assay and proved to be effective in inhibiting the morphogenic differentiation of cultured endothelial cells into capillary-like networks both in collagen gel and Matrigel models. In addition, POH reduced the cell number in a proliferation assay and induced apoptosis of endothelial cells as indicated by the POH-mediated increase of caspase-3 activity and DNA fragmentation. Consistent with the observed antisurvival effect, POH treatment resulted in a significant inhibition of Akt phosphorylation in endothelial cells. Finally, POH was able to differentially modulate the release of two important angiogenic regulators: vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2). POH decreased the release of VEGF from cancer cells but stimulated the expression of Ang2 by endothelial cells, indicating that it might suppress neovascularization and induce vessel regression. Overall, these data underscore the antiangiogenic potential of POH and suggest that POH, in addition to its anticancer activity, may be an effective agent in the treatment of angiogenesis-dependent diseases.

Address correspondence to: Dr. Andreas Papapetropoulos, Laboratory for Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Greece 26504. E-mail: apapapet{at}upatras.gr

This article has been cited by other articles:

				D. A. Wiseman, S. R. Werner, and P. L. Crowell Cell Cycle Arrest by the Isoprenoids Perillyl Alcohol, Geraniol, and Farnesol Is Mediated by p21Cip1 and p27Kip1 in Human Pancreatic Adenocarcinoma Cells J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1163 - 1170. [Abstract] [Full Text] [PDF]